Why Biogen Inc. (BIIB) is a Top Value Stock for the Long-Term [Yahoo! Finance]
Biogen Inc. (NASDAQ: BIIB) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.
Biogen Inc. (NASDAQ: BIIB) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating.
Biogen Inc. (NASDAQ: BIIB) was downgraded by analysts at BMO Capital Markets from an "outperform" rating to a "market perform" rating. They now have a $164.00 price target on the stock, down previously from $230.00.
Biogen Inc. (NASDAQ: BIIB) was downgraded by analysts at Stifel Nicolaus from a "buy" rating to a "hold" rating. They now have a $175.00 price target on the stock.